O. Simo et al. / Carbohydrate Research 340 (2005) 557–566
565
10 mL of freshly distilled TMU and irradiated for 24 h.
After evaporation of the solvent under reduced pressure,
the crude product was chromatographed on SiO2 with
97:3 CHCl3–MeOH. The purified C-glycosyl amino acid
16 was isolated as a white solid: 32 mg, 60% yield. TLC:
Rf 0.5 (SiO2; CHCl3–MeOH 9:1). Compound 16 showed
two equally populated conformers in Me2SO, most
likely due to cis/trans isomerization of the carbamate.
The NMR spectrum showed the absence of extraneous
lines except for the H2O signal at 3.30 ppm and the
(Cbz)]; 4.62–4.51 [m, 3H, –O–CH2– (allyl), H-a]; 4.19–
4.08 (m, 2H, 2 · H-6); 4.02, 3.98 [2 · d, 1H, CH (C-1–
CH2–N)]; 3.81, 3.74 [2 · d, 1H, CH (C-1–CH2–N)];
3.69–3.58 (m, 2H, 2 · H-60); 3.58–3.33 [m, 7H, 2 · H-
1, 2 · H-3, CH0 (C-1–CH2–N), 2 · H-4, overlapped with
H2O]; 3.32–3.12 [m, 3H, 2 · H-5, CH0 (C-1–CH2–N)];
3.07–2.94 (m, 2H, 2 · H-2); 2.94–2.81 (m, 2H, H-b, H-
b0); 13C NMR (126 MHz, Me2SO-d6, 298 K): d 171.4,
171.2 (C@O, a); 170.0, 169.8 (C@O, b); 155.80, 155.77
(C@O, Cbz); 137.81, 137.76, 136.9, 136.8 (arom.);
132.4 [–CH@CH2 (allyl)]; 128.8, 128.4, 128.3, 128.0,
127.9, 127.8, 127.7, 126.3 (arom.); 117.5, 117.4
(–CH@CH2, allyl); 100.64, 100.61 [Ph–CH (benzylid-
ene)]; 80.9, 80.8, 80.7 (C-4); 80.0, 79.9, 79.2, 79.1 (C-
1); 74.0, 73.82, 73.77 (C-3); 73.2, 73.1, 72.5, 72.3 (C-2);
70.1, 70.0, 69.9 (C-5); 67.94, 67.87 (C-6); 65.6 [Ph–
CH2–O– (Cbz)]; 64.9 [–O–CH2– (allyl)]; 50.8 (C-a);
50.27 (C-1–CH2–N); 48.8 (C-1–CH2–N); 34.8 (C-b).
HRFABMS: (m/z): [M+H]+ calcd for C43H51N2O15,
835.3289; found, 835.3336.
Me2SO-d6 signal at 2.50 ppm. 1H NMR (300 MHz,
3
Me2SO-d6, 298 K)
d
7.99 (dd, 1H, JNH-c,CHN
=
JNH-c,CH N 5.4 Hz, NH-c); 7.88 (d, 2H, 3J 7.5 Hz, arom.
Fmoc); 7.76–7.65 (m, 3H, NH-a, arom. Fmoc); 7.46–
7.27 [m, 9H, arom. Fmoc, Ph]; 5.86 [m, 1H, –CH@CH2
(allyl)]; 5.55, 5.53 (2 · s, 1H, benzylidene); 5.34–5.23 [m,
3H, CH@CH2 (allyl, trans), OH-3, OH-2]; 5.17 [dd,
3
0
3
1H, Jcis 10.5 Hz, CH@CH2 (allyl, cis)]; 4.53 [d, 2H,
–O–CH2– (allyl)]; 4.47 (m, 1H, H-a); 4.33–4.11 [m, 4H,
CH, CH2 (Fmoc), H-6]; 3.71–3.58 [m, 2H, H-60, CH
(C-1–CH2–N)]; 3.46–3.22 (m, 4H, H-3, H-4, H-5, H-1,
overlapped with H2O); 3.11–2.90 [m, 2H, H-2, CH0
(C-1–CH2–N)]; 2.72–2.48 (m, 2H, H-b, H-b0). FABMS:
(m/z): [M+H]+ calcd for C36H39N2O10, 559.26; found,
559.3. [M+Li]+ calcd for C36H38LiN2O10, 665.27; found,
665.3.
4.13. N-d,N-d-[Bis-C-(4,6-O-benzylidene-b-D-glucopyr-
anosylmethyl)]-N-a-tert-butoxycarbonyl-L-glutamine
tert-butyl ester (19)
The photoreactive glutamate 18 (11.6 mg, 0.024 mmol)
and
1-C-aminomethyl
glucoside
9
(19.8 mg,
4.12. N-c,N-c-[Bis-(4,6-O-benzylidene-b-D-glucopyrano-
syl methyl)]-N-a-benzyloxycarbonyl-L-asparagine allyl
ester (17)
0.036 mmol) were dissolved in THF-d8 in an NMR tube
under argon. The mixture was irradiated for 15 h with
four mercury lamps. The solvent was evaporated under
reduced pressure, and the crude product was chromato-
graphed on SiO2 with 95:5 CHCl3–MeOH. The C-glyco-
syl glutamine 19 was obtained as a white solid (10 mg,
50%): TLC: Rf 0.46 (SiO2; 95:5 CHCl3–MeOH). The
NMR spectrum showed the absence of extraneous lines
except for the THF signals at 3.58 and 1.73 ppm. The
two diastereotopic glucose spin systems, designated a
and b, were identified based on 1D TOCSY and HOHA-
The photoreactive amino acid 10 (9 mg, 0.017 mmol)
and the dimeric C-glycoside 9 (10.4 mg, 0.019 mmol)
were dissolved in 0.6 mL THF-d8 in a 5-mm NMR tube
under argon. The mixture was irradiated with four mer-
cury lamps for 20 h. The solvent was evaporated, and
the crude product was flash chromatographed on SiO2
with 95:5 CHCl3–MeOH. The C-glycosyl amino acid
was obtained as a white film (12 mg, 85%). TLC: Rf
0.20 (SiO2; 95:5 CHCl3–MeOH). The NMR spectrum
showed the absence of extraneous lines except for the
H2O signal at 3.35 ppm and the Me2SO-d6 signal at
2.50 ppm. The NMR spectra of 17 are quite complex
due to two diastereotopic glucose rings, as well as the
existence of two equally populated conformers. Due to
partial signal overlap in the HOHAHA, HSQC, and
HMBC spectra, the two conformers and the signals of
the diastereotopic glucose rings were not separately as-
signed. 1H NMR (500 MHz, Me2SO-d6, 298 K): d
7.39–7.28 (m, 16H, NH, arom.); 5.88 [m, 1H, –CH@
CH2 (allyl)]; 5.56, 5.55 [2s, 2H, 2 · Ph–H (benzylidene)];
5.44 (m, 1H, OH-2); 5.35 (d, 1H, 3JOH-3,3 4.9 Hz, OH-3);
HAspectra.
1H NMR (500 MHz, THF-d8 + D2O,
298 K): d 7.47–7.45 (m, 4H, arom.); 7.35–7.24 (m, 6H,
arom.); 6.38 (d, NH, not fully deuterium exchanged);
5.51 (s, 1H, CH–Ph); 5.49 (s, 1H, CH–Ph); 4.24 [dd,
3
3
0
1H, J6,6 10.4 Hz, J5,6 4.7 Hz, H-6 (a)]; 4.19 [dd, 1H,
3
3
J6,6 10.2 Hz, J5,6 4.8 Hz, H-6 (b)]; 3.97 (dd, 1H, Ja,b
3
0
3
0
9.3 Hz, Ja,b 4.7 Hz, H-a); 3.90 [m, 1H, CH (C-1–
CH2–N) (a)]; 3.82 [d, 1H, JCHN,CH N 13.8 Hz, CH (C-
2
0
1–CH2–N) (b)]; 3.69–3.61 [m, 3H, H-60 (a), H-60 (b),
CH0 (C-1–CH2–N) (b)]; 3.60–3.51 [m, 5H, CH0 (C-1–
CH2–N) (a), H-3 (a), H-3 (b), H-1 (a), H-1 (b)]; 3.41–
3.27 [m, 4H, H-4 (a), H-4 (b), H-5 (a), H-5 (b)], 3.17
3
[m, 1H, H-2 (a)]; 3.12 [dd, 1H, J1,2 = 3J2,3 9.0 Hz, H-2
(b)]; 2.65–2.51 (m, 2H, H-c, H-c0); 2.03 (m, 1H, H-b);
1.85 (m, 1H, H-b0); 1.45 (s, 9H, t-Bu), 1.43 (s, 9H, t-
Bu) ppm. FABMS: (m/z): [M+H]+ calcd for
C42H59N2O15, 831.3915; found, 831.3923.
3
5.30 [d, 1H, Jtrans 17.3 Hz, –CH@CH2 (allyl, trans)];
5.27 (1H, d, JOH-3,3 4.6 Hz, OH-3); 5.22–5.16 [m, 2H,
3
–CH@CH2 (allyl, cis), OH-2]; 5.09–5.00 [m, 2H, CH2